Year To Quarter End Statement Of Income

Carna Biosciences, Inc. - Filing #7610040

Concept 2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
Year to quarter end statement of income
Statement of income
Net sales
554,650,000 JPY
286,045,000 JPY
268,605,000 JPY
231,278,000 JPY
231,278,000 JPY
JPY
Cost of sales
42,483,000 JPY
38,677,000 JPY
Gross profit (loss)
512,167,000 JPY
192,601,000 JPY
Selling, general and administrative expenses
511,032,000 JPY
483,814,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
1,135,000 JPY
-107,969,000 JPY
109,105,000 JPY
-291,213,000 JPY
88,262,000 JPY
-379,475,000 JPY
Non-operating income
Interest income
44,000 JPY
39,000 JPY
Dividend income
101,000 JPY
99,000 JPY
Non-operating income
5,944,000 JPY
8,690,000 JPY
Non-operating expenses
Interest expenses
1,634,000 JPY
1,169,000 JPY
Non-operating expenses
2,502,000 JPY
1,532,000 JPY
Ordinary profit (loss)
4,576,000 JPY
-284,055,000 JPY
Extraordinary losses
Impairment losses
15,386,000 JPY
1,755,000 JPY
Extraordinary losses
15,386,000 JPY
1,755,000 JPY
Profit (loss) before income taxes
-10,809,000 JPY
-285,810,000 JPY
Income taxes - current
4,325,000 JPY
553,000 JPY
Income taxes - deferred
-30,000 JPY
-33,000 JPY
Income taxes
4,295,000 JPY
520,000 JPY
Profit (loss)
-15,104,000 JPY
-286,331,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.